DENTSPLY SIRONA Inc. (XRAY) Financial Statements (2023 and earlier)

Company Profile

Business Address 13320 BALLANTYNE CORPORATE PLACE
CHARLOTTE, NC 28277-3607
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3843 - Dental Equipment and Supplies (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments365418362374339281332
Cash and cash equivalents365418362374339281332
Receivables632645661707750732678
Inventory, net of allowances, customer advances and progress billings627592581553515548539
Inventory627592581553515548539
Prepaid expense104   89  
Deposits current assets24   22  
Other current assets88   84  
Other undisclosed current assets5328428126353244236
Total current assets:1,8931,9391,8851,8971,8521,8051,785
Noncurrent Assets
Operating lease, right-of-use asset200201205204198183184
Property, plant and equipment 714744771 771769
Intangible assets, net (including goodwill)4,5914,4595,9586,1726,2956,4026,521
Goodwill2,6882,5843,8583,9443,9764,0004,033
Intangible assets, net (excluding goodwill)1,9031,8752,1002,2282,3192,4022,488
Other noncurrent assets198209156128121128119
Other undisclosed noncurrent assets761   773  
Total noncurrent assets:5,7505,5837,0637,2757,3877,4847,593
TOTAL ASSETS:7,6437,5228,9489,1729,2399,2899,378
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,0061,0501,0211,0251,0791,048946
Taxes payable684454575244
Accounts payable279271289277262271281
Accrued liabilities727711688694760725621
Debt118246220347182151305
Other undisclosed current liabilities46      
Total current liabilities:1,1701,2961,2411,3721,2611,1991,251
Noncurrent Liabilities
Long-term debt and lease obligation1,8261,8911,9662,0292,0622,0642,085
Long-term debt, excluding current maturities1,8261,7371,8071,8721,9131,9251,946
Liabilities, other than long-term debt835721903907919963965
Deferred income tax liabilities287246409389391401415
Other liabilities399475494518528562550
Operating lease, liability149154159157149139139
Total noncurrent liabilities:2,6612,6122,8692,9362,9813,0273,050
Total liabilities:3,8313,9084,1104,3084,2424,2264,301
Equity
Equity, attributable to parent3,8113,6134,8374,8634,9965,0605,074
Common stock3333333
Treasury stock, value(2,649)(2,663)(2,666)(2,640)(2,535)(2,454)(2,458)
Additional paid in capital6,6296,6196,6176,5736,6066,6596,638
Accumulated other comprehensive loss(628)(844)(719)(629)(592)(567)(511)
Retained earnings4564981,6021,5561,5141,4191,402
Equity, attributable to noncontrolling interest1111133
Total equity:3,8123,6144,8384,8644,9975,0635,077
TOTAL LIABILITIES AND EQUITY:7,6437,5228,9489,1729,2399,2899,378

Income Statement (P&L) ($ in millions)

12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
Revenues9839471,0239691,1031,0401,067
Cost of revenue
(Cost of Goods and Services Sold)
(466)(439)(442)(448)(499)(471)(469)
Gross profit:517508581521604569598
Operating expenses(559)(1,629)(462)(424)(415)(437)(443)
Other undisclosed operating income (loss)107(97)  (17)  
Operating income (loss):65(1,218)11997172132155
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(38)(9)(13)2(4)(5)(5)
Interest and debt expense (14)(15)(12) (14)(16)
Other undisclosed income from continuing operations before equity method investments, income taxes41   43  
Income (loss) from continuing operations before equity method investments, income taxes:68(1,241)9187211113134
Other undisclosed loss from continuing operations before income taxes(60)   (55)  
Income (loss) from continuing operations before income taxes:8(1,241)9187156113134
Income tax expense (benefit)(23)164(18)(18)(37)(29)(35)
Income (loss) from continuing operations:(15)(1,077)73691198499
Income (loss) before gain (loss) on sale of properties:(1,077)73691198499
Net income (loss) available to common stockholders, diluted:(15)(1,077)73691198499

Comprehensive Income ($ in millions)

12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
Net income (loss):(15)(1,077)73691198499
Other comprehensive income (loss)216(125)(90)(37)(27)(56)43
Comprehensive income (loss):201(1,202)(17)329228142
Other undisclosed comprehensive income, net of tax, attributable to parent    2  
Comprehensive income (loss), net of tax, attributable to parent:201(1,202)(17)329428142

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: